Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylation
- 9 May 2006
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (19) , 7264-7269
- https://doi.org/10.1073/pnas.0509808103
Abstract
Activation of the noncanonical NF-κB signaling pathway involved in the proteolytic processing of NF-κB p100 to p52 is tightly regulated, and overproduction of p52 leads to lymphocyte hyperplasia and transformation. We have demonstrated that active but not latent Stat3, expressed in many types of human cancers involved in cell proliferation and survival, induces p100 processing to p52 by activation of IKKα and subsequent phosphorylation of p100. The Stat3-mediated p100 processing to p52 requires activation of Stat3 by the acetyltransferase activity of cAMP-response element-binding protein (CREB)-binding protein (CBP)/p300. A mutant of Stat3 defective in acetylation blocked Stat3-mediated p100 processing to p52 and acted as a dominant negative in blocking the production of p52. Furthermore, overexpression of p52 protected cells from apoptotic cell death. Thus, activation of the processing of p100 to p52 by Stat3 may represent one of the common pathways used by cancer cells to survive and escape therapy.Keywords
This publication has 39 references indexed in Scilit:
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- Essential Role of IκB Kinase α in the Constitutive Processing of NF-κB2 p100Journal of Biological Chemistry, 2005
- RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cellsThe Prostate, 2004
- Oncogenes, tumor suppressors and p52 NF-κBOncogene, 2003
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- STATs in oncogenesisOncogene, 2000
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- Stat Protein Transactivation Domains Recruit p300/CBP through Widely Divergent SequencesJournal of Biological Chemistry, 1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune ResponsesThe Journal of Experimental Medicine, 1998